Recent publications by Researchers affiliated with the Centre for Tropical Medicine and Global Health
Point-of-care C-reactive protein testing and antibiotic prescribing.
Althaus T. et al, (2021), The Lancet. Global health, 9
Causes of fever in primary care in Southeast Asia and the performance of C-reactive protein in discriminating bacterial from viral pathogens
Althaus T. et al, (2020), International Journal of Infectious Diseases, 96, 334 - 342
ACORN (A Clinically-Oriented Antimicrobial Resistance Surveillance Network): a pilot protocol for case based antimicrobial resistance surveillance
Turner P. et al, (2020), Wellcome Open Research, 5, 13 - 13
Determinants of MDA impact and designing MDAs towards malaria elimination
Gao B. et al, (2020), eLife, 9
Sensitivity of C‐reactive protein for the identification of patients with laboratory‐confirmed bacterial infections in northern Tanzania
Althaus T. et al, (2020), Tropical Medicine & International Health, 25, 291 - 300
Prevalence of Group A Streptococcus in Primary Care Patients and the Utility of C-Reactive Protein and Clinical Scores for Its Identification in Thailand
Greer R. et al, (2020), The American Journal of Tropical Medicine and Hygiene, 102, 377 - 383
ACORN (A Clinically-Oriented Antimicrobial Resistance Surveillance Network): a pilot protocol for case based antimicrobial resistance surveillance
Turner P. et al, (2020), Wellcome Open Research, 5, 13 - 13
ACORN (A Clinically-Oriented Antimicrobial Resistance Surveillance Network): a pilot protocol for case based antimicrobial resistance surveillance.
Turner P. et al, (2020), Wellcome open research, 5
How context can impact clinical trials: a multi-country qualitative case study comparison of diagnostic biomarker test interventions
Haenssgen MJ. et al, (2019), Trials, 20
Provider and household costs of Plasmodium vivax malaria episodes: a multicountry comparative analysis of primary trial data
Devine A. et al, (2019), Bulletin of the World Health Organization, 97, 828 - 836
Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial
Taylor WRJ. et al, (2019), The Lancet, 394, 929 - 938
Accounting for aetiology: can regional surveillance data alongside host biomarker-guided antibiotic therapy improve treatment of febrile illness in remote settings?
Chandna A. et al, (2019), Wellcome Open Research, 4, 1 - 1
Antibiotic knowledge, attitudes and practices: new insights from cross-sectional rural health behaviour surveys in low-income and middle-income South-East Asia
Haenssgen MJ. et al, (2019), BMJ Open, 9, e028224 - e028224
The cost-effectiveness of the use of selective media for the diagnosis of melioidosis in different settings
Dance DAB. et al, (2019), PLOS Neglected Tropical Diseases, 13, e0007598 - e0007598
Valuing the Unpaid Contribution of Community Health Volunteers to Mass Drug Administration Programs.
Turner HC. et al, (2019), Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 68, 1588 - 1595
The impact of targeted malaria elimination with mass drug administrations on falciparum malaria in Southeast Asia: A cluster randomised trial
von Seidlein L. et al, (2019), PLOS Medicine, 16, e1002745 - e1002745
Accounting for aetiology: can regional surveillance data alongside host biomarker-guided antibiotic therapy improve treatment of febrile illness in remote settings?
Chandna A. et al, (2019), Wellcome Open Research, 4, 1 - 1
COSTING MASS DRUG ADMINISTRATION WITH DIFFERENT TARGETING STRATEGIES
Kyaw SS. et al, (2019), AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 101, 123 - 123
Effect of point-of-care C-reactive protein testing on antibiotic prescription in febrile patients attending primary care in Thailand and Myanmar: an open-label, randomised, controlled trial
Althaus T. et al, (2019), The Lancet Global Health, 7, e119 - e131